Insider · CIK 0001790215

Brennan Nora

Reports to the SEC for 3 companies · NEWTOWN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001790215

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-31	SPECTRUM PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−105K sh	—	—	0
2023-07-31	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−1.52M sh	—	—	0
2023-07-31	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−840K sh	—	—	0
2023-07-31	SPECTRUM PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−463K sh	—	—	0
2023-05-26	SPECTRUM PHARMACEUTICALS INCS Sale	See Remarks	SSale	−32.4K sh	$1.10	−$35.5K	567,828
2023-01-03	SPECTRUM PHARMACEUTICALS INCA Award	See Remarks	AAward	+240K sh	—	—	600,215
2023-01-03	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	See Remarks	AAward	+840K sh	—	—	840,000
2022-06-21	SPECTRUM PHARMACEUTICALS INCS Sale	See Remarks	SSale	−3,569 sh	$0.79	−$2,801.665	360,215
2022-06-21	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	See Remarks	AAward	+1.52M sh	—	—	1,515,957
2022-06-21	SPECTRUM PHARMACEUTICALS INCA Award	See Remarks	AAward	+335K sh	—	—	363,784
2021-06-17	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	See Remarks	AAward	+67.8K sh	—	—	67,804
2021-06-17	SPECTRUM PHARMACEUTICALS INCA Award	See Remarks	AAward	+14.3K sh	—	—	29,277
2021-03-31	TELATELA Bio, Inc.A Award	Chief Financial Officer	AAward	+2,928 sh	—	—	17,696
2021-02-24	TELATELA Bio, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+20.1K sh	—	—	20,100
2021-02-24	TELATELA Bio, Inc.A Award	Chief Financial Officer	AAward	+11.1K sh	—	—	14,768
2020-12-10	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	See Remarks	AAward	+30K sh	—	—	30,000
2020-12-10	SPECTRUM PHARMACEUTICALS INCA Award	See Remarks	AAward	+15K sh	—	—	15,000
2019-11-13	TELATELA Bio, Inc. · Series B Preferred StockC Conversion	Chief Financial Officer	CConversion	−86.2K sh	—	—	0
2019-11-13	TELATELA Bio, Inc.C Conversion	Chief Financial Officer	CConversion	+3,491 sh	—	—	3,668

Recent filings

Accepted (ET)
Aug 14
Brennan Nora0000899243-23-017673
SEC(opens sec.gov)
May 304
Brennan Nora0000950170-23-025014
SEC(opens sec.gov)
Jan 54
Brennan Nora0000899243-23-001064
SEC(opens sec.gov)
Jun 234
Brennan Nora0001209191-22-039057
SEC(opens sec.gov)
Jun 224
Brennan Nora0001209191-21-042511
SEC(opens sec.gov)
Apr 24
Brennan Nora0001192482-21-000297
SEC(opens sec.gov)
Feb 264
Brennan Nora0001192482-21-000189
SEC(opens sec.gov)
Dec 144
Brennan Nora0001209191-20-063198
SEC(opens sec.gov)
Nov 134
Brennan Nora0001192482-19-000425
SEC(opens sec.gov)

Companies

Address

12 PENNS TRAIL

NEWTOWN, PA, 18940